Trade 23andMe Holding Co. - ME CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026346% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004124% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 0.93 |
Open* | 0.94 |
1-Year Change* | -70.16% |
Day's Range* | 0.91 - 0.94 |
52 wk Range | 0.61-3.48 |
Average Volume (10 days) | 4.10M |
Average Volume (3 months) | 73.16M |
Market Cap | 413.61M |
P/E Ratio | -100.00K |
Shares Outstanding | 479.11M |
Revenue | 270.18M |
EPS | -0.73 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Feb 9, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 5, 2023 | 0.93 | 0.00 | 0.00% | 0.93 | 0.95 | 0.89 |
Dec 4, 2023 | 0.94 | 0.07 | 8.05% | 0.87 | 0.97 | 0.87 |
Dec 1, 2023 | 0.87 | 0.02 | 2.35% | 0.85 | 0.90 | 0.81 |
Nov 30, 2023 | 0.83 | -0.05 | -5.68% | 0.88 | 0.89 | 0.83 |
Nov 29, 2023 | 0.87 | 0.00 | 0.00% | 0.87 | 0.91 | 0.83 |
Nov 28, 2023 | 0.85 | -0.03 | -3.41% | 0.88 | 0.88 | 0.83 |
Nov 27, 2023 | 0.88 | -0.02 | -2.22% | 0.90 | 0.90 | 0.86 |
Nov 24, 2023 | 0.91 | 0.06 | 7.06% | 0.85 | 0.91 | 0.85 |
Nov 22, 2023 | 0.85 | 0.00 | 0.00% | 0.85 | 0.85 | 0.82 |
Nov 21, 2023 | 0.84 | -0.02 | -2.33% | 0.86 | 0.86 | 0.81 |
Nov 20, 2023 | 0.88 | 0.05 | 6.02% | 0.83 | 0.90 | 0.82 |
Nov 17, 2023 | 0.83 | 0.07 | 9.21% | 0.76 | 0.84 | 0.75 |
Nov 16, 2023 | 0.74 | -0.10 | -11.90% | 0.84 | 0.84 | 0.73 |
Nov 15, 2023 | 0.81 | -0.03 | -3.57% | 0.84 | 0.86 | 0.81 |
Nov 14, 2023 | 0.81 | 0.00 | 0.00% | 0.81 | 0.85 | 0.78 |
Nov 13, 2023 | 0.80 | 0.08 | 11.11% | 0.72 | 0.84 | 0.71 |
Nov 10, 2023 | 0.71 | 0.01 | 1.43% | 0.70 | 0.73 | 0.69 |
Nov 9, 2023 | 0.69 | -0.17 | -19.77% | 0.86 | 0.86 | 0.69 |
Nov 8, 2023 | 0.88 | -0.01 | -1.12% | 0.89 | 0.90 | 0.86 |
Nov 7, 2023 | 0.89 | 0.02 | 2.30% | 0.87 | 0.89 | 0.84 |
23andMe Holding Co. Events
Time (UTC) | Country | Event |
---|---|---|
Friday, February 9, 2024 | ||
Time (UTC) 21:05 | Country US
| Event Q3 2024 23andMe Holding Co. Earnings Release Q3 2024 23andMe Holding Co. Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total revenue | 299.489 | 271.893 | 243.92 | 305.463 | 440.9 |
Revenue | 299.489 | 271.893 | 243.92 | 305.463 | 440.9 |
Cost of Revenue, Total | 164.993 | 138.948 | 126.914 | 168.031 | 248.01 |
Gross Profit | 134.496 | 132.945 | 117.006 | 137.432 | 192.89 |
Total Operating Expense | 623.5 | 526.046 | 429.116 | 563.91 | 629.683 |
Selling/General/Admin. Expenses, Total | 235.911 | 197.721 | 142.346 | 169.911 | 241.141 |
Research & Development | 222.596 | 189.377 | 159.856 | 181.276 | 140.532 |
Unusual Expense (Income) | 0 | 0 | 44.692 | 0 | |
Operating Income | -324.011 | -254.153 | -185.196 | -258.447 | -188.783 |
Interest Income (Expense), Net Non-Operating | 9.676 | 0.277 | 1.577 | 7.584 | 5.25 |
Net Income Before Taxes | -314.428 | -220.97 | -183.619 | -250.863 | -183.533 |
Net Income After Taxes | -311.656 | -217.49 | -183.619 | -250.863 | -183.533 |
Net Income Before Extra. Items | -311.656 | -217.49 | -183.619 | -250.863 | -183.533 |
Net Income | -311.656 | -217.49 | -183.619 | -250.863 | -183.533 |
Income Available to Common Excl. Extra. Items | -311.656 | -217.49 | -183.619 | -250.863 | -183.533 |
Income Available to Common Incl. Extra. Items | -311.656 | -217.49 | -183.619 | -250.863 | -183.533 |
Diluted Net Income | -311.656 | -217.49 | -183.619 | -250.863 | -183.533 |
Diluted Weighted Average Shares | 451.504 | 361.528 | 43.4498 | 38.4538 | 34.4825 |
Diluted EPS Excluding Extraordinary Items | -0.69026 | -0.60159 | -4.226 | -6.52376 | -5.3225 |
Diluted Normalized EPS | -0.67591 | -0.60159 | -4.21449 | -5.34333 | -5.3225 |
Other, Net | -0.093 | 32.906 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 60.864 | 92.377 | 66.94 | 75.659 | 64.513 |
Revenue | 60.864 | 92.377 | 66.94 | 75.659 | 64.513 |
Cost of Revenue, Total | 30.184 | 52.395 | 36.189 | 37.386 | 39.023 |
Gross Profit | 30.68 | 39.982 | 30.751 | 38.273 | 25.49 |
Total Operating Expense | 170.128 | 161.651 | 164.04 | 143.7 | 154.109 |
Selling/General/Admin. Expenses, Total | 73.398 | 48.537 | 70.581 | 53.716 | 63.077 |
Research & Development | 62.329 | 60.719 | 57.27 | 52.598 | 52.009 |
Unusual Expense (Income) | 4.217 | ||||
Operating Income | -109.264 | -69.274 | -97.1 | -68.041 | -89.596 |
Interest Income (Expense), Net Non-Operating | 4.307 | 4.369 | 3.671 | 1.392 | 0.245 |
Other, Net | 0.333 | 0.174 | 0.855 | -0.687 | -0.435 |
Net Income Before Taxes | -104.624 | -64.731 | -92.574 | -67.336 | -89.786 |
Net Income After Taxes | -104.624 | -64.098 | -91.961 | -66.065 | -89.532 |
Net Income Before Extra. Items | -104.624 | -64.098 | -91.961 | -66.065 | -89.532 |
Net Income | -104.624 | -64.098 | -91.961 | -66.065 | -89.532 |
Income Available to Common Excl. Extra. Items | -104.624 | -64.098 | -91.961 | -66.065 | -89.532 |
Income Available to Common Incl. Extra. Items | -104.624 | -64.098 | -91.961 | -66.065 | -89.532 |
Diluted Net Income | -104.624 | -64.098 | -91.961 | -66.065 | -89.532 |
Diluted Weighted Average Shares | 462.254 | 456.168 | 453.407 | 449.9 | 446.505 |
Diluted EPS Excluding Extraordinary Items | -0.22633 | -0.14051 | -0.20282 | -0.14684 | -0.20052 |
Diluted Normalized EPS | -0.21668 | -0.14051 | -0.18853 | -0.14655 | -0.20023 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 424.992 | 601.789 | 313.575 | 252.521 | |
Cash and Short Term Investments | 386.849 | 553.182 | 282.489 | 207.942 | |
Cash | 386.849 | 553.182 | 282.489 | 207.942 | |
Total Receivables, Net | 1.897 | 3.38 | 2.481 | 6.392 | |
Accounts Receivable - Trade, Net | 1.897 | 3.38 | 2.481 | 6.392 | |
Total Inventory | 10.247 | 10.789 | 6.239 | 14.122 | |
Prepaid Expenses | 19.224 | 25.139 | 15.485 | 13.088 | |
Other Current Assets, Total | 6.775 | 9.299 | 6.881 | 10.977 | |
Total Assets | 942.598 | 1152.07 | 452.098 | 404.63 | |
Property/Plant/Equipment, Total - Net | 94.686 | 105.428 | 124.006 | 138.49 | |
Property/Plant/Equipment, Total - Gross | 170.002 | 168.052 | 174.334 | 172.773 | |
Accumulated Depreciation, Total | -75.316 | -62.624 | -50.328 | -34.283 | |
Intangibles, Net | 61.181 | 83.54 | 6.889 | 5.417 | |
Other Long Term Assets, Total | 9.995 | 9.567 | 7.628 | 8.202 | |
Total Current Liabilities | 149.416 | 153.241 | 121.619 | 139.448 | |
Accounts Payable | 12.924 | 37.93 | 12.271 | 13.085 | |
Accrued Expenses | 72.615 | 50.336 | 37.758 | 41.616 | |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 63.877 | 64.975 | 71.59 | 84.747 | |
Total Liabilities | 228.659 | 236.412 | 210.366 | 270.43 | |
Total Long Term Debt | 0 | 0 | 0 | 0 | |
Other Liabilities, Total | 79.243 | 83.171 | 88.747 | 130.982 | |
Total Equity | 713.939 | 915.656 | 241.732 | 134.2 | |
Redeemable Preferred Stock | 0 | 837.351 | 755.083 | ||
Common Stock | 0.046 | 0.045 | 0 | 0 | |
Additional Paid-In Capital | 2220.9 | 2110.16 | 381.619 | 172.736 | |
Retained Earnings (Accumulated Deficit) | -1506.38 | -1194.73 | -977.238 | -793.619 | |
Total Liabilities & Shareholders’ Equity | 942.598 | 1152.07 | 452.098 | 404.63 | |
Total Common Shares Outstanding | 461.2 | 448.812 | 54.2921 | 44.3183 | |
Total Preferred Shares Outstanding | 91.1984 | 86.4433 | |||
Goodwill, Net | 351.744 | 351.744 | |||
Other Equity, Total | -0.62 | 0.179 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 297.995 | 360.276 | 424.992 | 508.671 | 506.205 |
Cash and Short Term Investments | 256.386 | 314.351 | 386.849 | 432.801 | 410.891 |
Cash | 256.386 | 314.351 | 386.849 | 432.801 | 410.891 |
Total Receivables, Net | 1.501 | 4.124 | 1.897 | 26.808 | 52.883 |
Accounts Receivable - Trade, Net | 1.501 | 4.124 | 1.897 | 26.808 | 52.883 |
Total Inventory | 14.979 | 11.815 | 10.247 | 11.96 | 13.806 |
Prepaid Expenses | 17.948 | 21.286 | 19.224 | 21.367 | 20.24 |
Other Current Assets, Total | 7.181 | 8.7 | 6.775 | 15.735 | 8.385 |
Total Assets | 801.23 | 871.199 | 942.598 | 1024.65 | 1040.73 |
Property/Plant/Equipment, Total - Net | 85.354 | 90.033 | 94.686 | 90.778 | 95.945 |
Property/Plant/Equipment, Total - Gross | 166.116 | 167.794 | 170.002 | 162.96 | 165.783 |
Accumulated Depreciation, Total | -80.762 | -77.761 | -75.316 | -72.182 | -69.838 |
Intangibles, Net | 56.806 | 59.56 | 61.181 | 63.185 | 76.435 |
Other Long Term Assets, Total | 9.331 | 9.586 | 9.995 | 10.276 | 10.403 |
Total Current Liabilities | 101.601 | 118.909 | 149.416 | 200.113 | 144.906 |
Accounts Payable | 8.546 | 12.748 | 12.924 | 13.984 | 10.549 |
Accrued Expenses | 51.899 | 56.695 | 72.615 | 75.624 | 51.233 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 41.156 | 49.466 | 63.877 | 110.505 | 83.124 |
Total Liabilities | 175.979 | 195.709 | 228.659 | 273.662 | 221.412 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 74.378 | 76.8 | 79.243 | 73.549 | 76.506 |
Total Equity | 625.251 | 675.49 | 713.939 | 750.992 | 819.32 |
Redeemable Preferred Stock | |||||
Common Stock | 0.048 | 0.047 | 0.046 | 0.045 | 0.045 |
Additional Paid-In Capital | 2311.48 | 2287.41 | 2220.9 | 2193.54 | 2167.97 |
Retained Earnings (Accumulated Deficit) | -1686.28 | -1611.01 | -1506.38 | -1442.29 | -1350.32 |
Total Liabilities & Shareholders’ Equity | 801.23 | 871.199 | 942.598 | 1024.65 | 1040.73 |
Total Common Shares Outstanding | 478.831 | 472.096 | 461.2 | 457.161 | 455.453 |
Goodwill, Net | 351.744 | 351.744 | 351.744 | 351.744 | 351.744 |
Other Equity, Total | 0 | -0.954 | -0.62 | -0.311 | 1.632 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Net income/Starting Line | -311.656 | -217.49 | -183.619 | -250.863 | -183.533 |
Cash From Operating Activities | -165.39 | -166.828 | -74.252 | -185.766 | -98.117 |
Cash From Operating Activities | 32.071 | 23.699 | 18.078 | 22.249 | 9.901 |
Amortization | 4.427 | 2.449 | 2.168 | 1.04 | 0 |
Non-Cash Items | 125.725 | 16.23 | 71.396 | 42.724 | 52.952 |
Changes in Working Capital | -15.957 | 8.284 | 17.725 | -0.916 | 22.563 |
Cash From Investing Activities | -11.305 | -108.137 | -6.536 | -72.823 | -27.84 |
Capital Expenditures | -11.31 | -13.973 | -7.374 | -73.588 | -27.84 |
Other Investing Cash Flow Items, Total | 0.005 | -94.164 | 0.838 | 0.765 | 0 |
Cash From Financing Activities | 9.777 | 546.004 | 155.335 | 8.83 | 344.448 |
Financing Cash Flow Items | -0.89 | -30.642 | -3.316 | 0 | -0.394 |
Issuance (Retirement) of Stock, Net | 10.667 | 576.646 | 158.651 | 8.83 | 344.842 |
Net Change in Cash | -166.533 | 270.893 | 74.547 | -249.759 | 218.491 |
Foreign Exchange Effects | 0.385 | -0.146 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -311.656 | -247.558 | -155.597 | -89.532 | -217.49 |
Cash From Operating Activities | -165.39 | -120.429 | -145.974 | -73.04 | -166.828 |
Cash From Operating Activities | 32.071 | 24.918 | 16.747 | 8.36 | 23.699 |
Amortization | 4.427 | 3.214 | 2.078 | 1.052 | 2.449 |
Non-Cash Items | 125.725 | 149.89 | 78.418 | 17.355 | 16.23 |
Changes in Working Capital | -15.957 | -50.893 | -87.62 | -10.275 | 8.284 |
Cash From Investing Activities | -11.305 | -8.017 | -4.951 | -2.9 | -108.137 |
Capital Expenditures | -11.31 | -8.017 | -4.953 | -2.9 | -13.973 |
Other Investing Cash Flow Items, Total | 0.005 | 0 | 0.002 | -94.164 | |
Cash From Financing Activities | 9.777 | 7.171 | 7.182 | 1.533 | 546.004 |
Financing Cash Flow Items | -0.89 | 0 | 0 | 0 | -30.642 |
Issuance (Retirement) of Stock, Net | 10.667 | 7.171 | 7.182 | 1.533 | 576.646 |
Net Change in Cash | -166.533 | -120.581 | -142.291 | -73.784 | 270.893 |
Foreign Exchange Effects | 0.385 | 0.694 | 1.452 | 0.623 | -0.146 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.9385 | 27256007 | -306490 | 2023-06-30 | LOW |
Newview Capital Management, LLC. | Venture Capital | 6.3804 | 19455681 | 0 | 2023-06-30 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.6897 | 17349340 | 717618 | 2023-06-30 | LOW |
Euclidean Capital, L.L.C. | Investment Advisor | 3.3592 | 10243122 | 0 | 2023-06-30 | MED |
Fidelity Management & Research Company LLC | Investment Advisor | 2.2996 | 7012254 | 187220 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.0278 | 6183243 | 576924 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8421 | 5617120 | 254321 | 2023-06-30 | LOW |
Sapphire Ventures, LLC | Investment Advisor/Hedge Fund | 1.7354 | 5291824 | 0 | 2023-06-30 | MED |
Wojcicki (Anne) | Individual Investor | 1.0762 | 3281613 | -312356 | 2023-07-10 | |
Renaissance Technologies LLC | Hedge Fund | 0.8227 | 2508729 | 977329 | 2023-06-30 | HIGH |
Alibaba Group Holding Ltd. | Corporation | 0.6947 | 2118444 | 0 | 2023-06-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.6907 | 2106225 | 21160 | 2023-06-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.6692 | 2040726 | -83543 | 2023-06-30 | LOW |
Voya Investment Management LLC | Investment Advisor/Hedge Fund | 0.5418 | 1652033 | 726742 | 2023-06-30 | LOW |
ACATIS Investment Kapitalverwaltungsgesellschaft GmbH | Investment Advisor | 0.4919 | 1500000 | 0 | 2023-06-30 | LOW |
Morgan Stanley Investment Management Inc. (US) | Investment Advisor/Hedge Fund | 0.4368 | 1332011 | -813862 | 2023-06-30 | LOW |
Lovell (Evan M) | Individual Investor | 0.4029 | 1228544 | 1217077 | 2022-08-11 | |
Two Sigma Investments, LP | Hedge Fund | 0.3974 | 1211636 | -995506 | 2023-06-30 | HIGH |
Hibbs (Kathy L) | Individual Investor | 0.3754 | 1144697 | 0 | 2023-10-19 | HIGH |
Selsavage (Joseph Anthony) | Individual Investor | 0.3657 | 1115162 | 1025992 | 2023-09-15 | MED |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
23andMe Holding Co. Company profile
23andMe Holding Co. operates as a consumer genetics and research company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers'' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize promising drugs. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. The company was founded in 2006 and is headquartered in Sunnyvale, California.Industry: | Medical & Diagnostic Laboratories |
349 Oyster Point Boulevard
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com